PHARVARIS NV (PHVS) Fundamental Analysis & Valuation

NASDAQ:PHVS • NL00150005Y4

Current stock price

28.685 USD
+0.8 (+2.89%)
Last:

This PHVS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PHVS Profitability Analysis

1.1 Basic Checks

  • PHVS had negative earnings in the past year.
  • In the past year PHVS has reported a negative cash flow from operations.
  • PHVS had negative earnings in each of the past 5 years.
  • PHVS had a negative operating cash flow in each of the past 5 years.
PHVS Yearly Net Income VS EBIT VS OCF VS FCFPHVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • The Return On Assets of PHVS (-58.28%) is worse than 69.11% of its industry peers.
  • PHVS has a Return On Equity (-64.77%) which is in line with its industry peers.
Industry RankSector Rank
ROA -58.28%
ROE -64.77%
ROIC N/A
ROA(3y)-43.22%
ROA(5y)-39.06%
ROE(3y)-47.05%
ROE(5y)-42.63%
ROIC(3y)N/A
ROIC(5y)N/A
PHVS Yearly ROA, ROE, ROICPHVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • PHVS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHVS Yearly Profit, Operating, Gross MarginsPHVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

6

2. PHVS Health Analysis

2.1 Basic Checks

  • PHVS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHVS has more shares outstanding
  • Compared to 1 year ago, PHVS has an improved debt to assets ratio.
PHVS Yearly Shares OutstandingPHVS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
PHVS Yearly Total Debt VS Total AssetsPHVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 27.79 indicates that PHVS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of PHVS (27.79) is better than 91.10% of its industry peers.
  • PHVS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • PHVS has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 27.79
ROIC/WACCN/A
WACCN/A
PHVS Yearly LT Debt VS Equity VS FCFPHVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • PHVS has a Current Ratio of 10.11. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 10.11, PHVS is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
  • PHVS has a Quick Ratio of 10.11. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PHVS (10.11) is better than 80.10% of its industry peers.
Industry RankSector Rank
Current Ratio 10.11
Quick Ratio 10.11
PHVS Yearly Current Assets VS Current LiabilitesPHVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1

3. PHVS Growth Analysis

3.1 Past

  • PHVS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.85%.
EPS 1Y (TTM)-20.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PHVS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.95% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.39%
EPS Next 2Y6.65%
EPS Next 3Y16.21%
EPS Next 5Y27.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHVS Yearly Revenue VS EstimatesPHVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
PHVS Yearly EPS VS EstimatesPHVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10

0

4. PHVS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PHVS. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHVS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHVS Price Earnings VS Forward Price EarningsPHVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHVS Per share dataPHVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • PHVS's earnings are expected to grow with 16.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y16.21%

0

5. PHVS Dividend Analysis

5.1 Amount

  • No dividends for PHVS!.
Industry RankSector Rank
Dividend Yield 0%

PHVS Fundamentals: All Metrics, Ratios and Statistics

PHARVARIS NV

NASDAQ:PHVS (4/14/2026, 2:26:28 PM)

28.685

+0.8 (+2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-02
Earnings (Next)05-11
Inst Owners58.88%
Inst Owner Change0%
Ins Owners5.32%
Ins Owner Change-0.2%
Market Cap1.88B
Revenue(TTM)N/A
Net Income(TTM)-175.70M
Analysts85.26
Price Target47.08 (64.13%)
Short Float %1.82%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.7%
Min EPS beat(2)-13.69%
Max EPS beat(2)12.28%
EPS beat(4)1
Avg EPS beat(4)-4.04%
Min EPS beat(4)-13.69%
Max EPS beat(4)12.28%
EPS beat(8)4
Avg EPS beat(8)-1.86%
EPS beat(12)7
Avg EPS beat(12)-2.72%
EPS beat(16)10
Avg EPS beat(16)-0.6%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.52%
PT rev (3m)0.52%
EPS NQ rev (1m)-9.89%
EPS NQ rev (3m)-9.89%
EPS NY rev (1m)-7.13%
EPS NY rev (3m)-7.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.92
P/tB 5.92
EV/EBITDA N/A
EPS(TTM)-3.5
EYN/A
EPS(NY)-3.52
Fwd EYN/A
FCF(TTM)-2.45
FCFYN/A
OCF(TTM)-2.45
OCFYN/A
SpS0
BVpS4.85
TBVpS4.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -58.28%
ROE -64.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.22%
ROA(5y)-39.06%
ROE(3y)-47.05%
ROE(5y)-42.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.34%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.11
Quick Ratio 10.11
Altman-Z 27.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)91.29%
Cap/Depr(5y)103.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
EPS Next Y-0.39%
EPS Next 2Y6.65%
EPS Next 3Y16.21%
EPS Next 5Y27.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.37%
EBIT Next 3Y34.47%
EBIT Next 5Y31.88%
FCF growth 1Y-13.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.1%
OCF growth 3YN/A
OCF growth 5YN/A

PHARVARIS NV / PHVS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PHARVARIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to PHVS.


What is the valuation status for PHVS stock?

ChartMill assigns a valuation rating of 0 / 10 to PHARVARIS NV (PHVS). This can be considered as Overvalued.


What is the profitability of PHVS stock?

PHARVARIS NV (PHVS) has a profitability rating of 0 / 10.


How financially healthy is PHARVARIS NV?

The financial health rating of PHARVARIS NV (PHVS) is 6 / 10.